{"version":"1.0","type":"link","title":"Risk of cardiovascular disease following degarelix versus gonadotropin-releasing hormone agonists in patients with prostate cancer: a systematic review and meta-analysis.","author_name":"Odat RM 외","author_url":"https://prs-insight.online/author/Odat%20RM","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/138643","thumbnail_width":1200,"thumbnail_height":630}